In our study here, we validate that circulating GHRA inhibits the gene expression of ABCB1 and ABCG2 in the HCC tumors and markedly sensitizes tumors to sorafenib effect to the extent of complete remission in some of the experimental mice. Here, ABCG2 is linked to hepatocellular carcinoma.